OverviewSuggest Edit

    IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. It utilizes a platform that integrates access to a dynamic IMID patient biobank, curated clinical data, proprietary multiomics molecular data, and clinical expertise. IMIDomics analytics platform extracts insights into disease biology and patient conditions through a proprietary interactive portal.

    Latest Updates

    Employees (est.) (May 2020)3
    Cybersecurity ratingBMore

    IMIDomics Financials and Metrics

    Summary Metrics

    Founding Date


    IMIDomics Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    IMIDomics Online and Social Media Presence

    Embed Graph

    IMIDomics Frequently Asked Questions

    • When was IMIDomics founded?

      IMIDomics was founded in 2015.

    • How many employees does IMIDomics have?

      IMIDomics has 3 employees.

    • Who are IMIDomics competitors?

      Competitors of IMIDomics include ImevaX, Appello Pharmaceuticals and BioArctic.